Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CRGX is expected to report earnings to rise 23.16% to -116 cents per share on May 30
Q1'25
Est.
$-1.17
Q4'24
Beat
by $0.73
Q3'24
Beat
by $0.73
Q2'24
Beat
by $0.39
Q1'24
Beat
by $0.38
The last earnings report on March 21 showed earnings per share of -94 cents, beating the estimate of -167 cents. With 788.32K shares outstanding, the current market capitalization sits at 195.98M.